Observance of Anticonvulsant Treatments and Quality of Life of Epileptic Children

NCT03753035 | Unknown

• 1 other identifier: ObEPI
• Study Type: observational
• Target: 75
• Locations: 1 country
• Sites: 1

Brief Summary

There is little epidemiological data in the literature on the therapeutic compliance of epileptic children. Yet it is a fundamental issue in the therapeutic education and balance of this pathology. To obtain more epidemiological precision on the observance of epileptic children and to propose, according to the factors involved, the improvement of practices (therapeutic education ..). Propose an evaluation of the quality of life of their children by a suitable self-questionnaire.

Conditions

Epilepsy; Children, Only; Quality of Life; Seizures; Patient Compliance

Keywords

epilepsy; children; seizures; patient compliance; quality of life

Outcome Measures

Primary Outcomes (1)

• Mean compliance

  Mean compliance score measured by the validated Modified Morisky Medication Adherence Scales 8 for epileptic patients 11 subscale with a 5-point Likert scale. According to the scoring system for the MMAS, 8=high adherence, 6 to \<8=medium adherence, and \<6=low adherence. Patients who had a low or a moderate rate of adherence were considered nonadherent5.

  6 months

Secondary Outcomes (3)

• Compliance score of the modified Modified Morisky Medication Adherence Scales 8

  6 months

• quality of life of epileptic children

  6 months

• syndromes

  6 months

Study Arms (1)

epileptic children

Completion of questionnaire, during medical consultation, on compliance and quality of life

Eligibility Criteria

• Age: 5 Years - 18 Years
• Sex: all
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

all epileptic children at Nancy Children Hospital

You may qualify if:

• Child aged 5 to 17
• Child who has received complete information on the organization of the research and who has not objected to his participation and the exploitation of his data
• Holder (s) of the parental authority present (s) having received the complete information on the organization of the research and not being opposed to the participation and the exploitation of the data of his child
• Epileptic child
• Follow-up at the neuro pediatric department of CHRU Nancy

You may not qualify if:

• epileptic encephalopathy
• Multiply handicapped child

Sponsors & Collaborators

• Central Hospital, Nancy, France: lead

Study Sites (1)

GIRARD

Nancy, Lorraine, 54520, France

RECRUITING

MeSH Terms

Conditions

Epilepsy; Seizures; Patient Compliance

Condition Hierarchy (Ancestors)

Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Patient Acceptance of Health Care; Treatment Adherence and Compliance; Health Behavior; Behavior

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: November 22, 2018
• First Posted: November 26, 2018
• Study Start: November 29, 2018
• Primary Completion: April 30, 2019
• Study Completion: September 30, 2019
• Last Updated: April 16, 2019

Record last verified: 2019-04

Locations

FR (1)